Bioengineered Artificial Skin MarketSize and Trends

Global bioengineered artificial skin market is value at US$ 3.32 Billion In 2023 and is expected to grow at a compound annual growth rate (CAGR) of 16.9% to reach US$ 9.92 Billion by 2030. Factors such as increasing healthcare spending, rising demand for regenerative medicine, and technological advancements in skin substitute products are also expected to drive the growth of the bioengineered artificial skin market.

The global bioengineered artificial skin market is expected to experience significant growth in the near future, driven by increasing demand for skin substitutes for wound healing and reconstruction, and technological advancements in skin substitute products.

Global Bioengineered Artificial Skin Market Trends:

Development of advanced skin substitutes: The development of advanced bioengineered skin substitutes, including bilayered and trilayered substitutes, is a significant trend in the market. These products offer improved wound healing and tissue regeneration properties, leading to increased demand and adoption for regenerative based medicine. For instance, in August 2023, according to an article published by Frontiers in medicine Journal ‘Skin substitutes as treatment for chronic wounds’, ABnion-derived skin substitutes include dehydrated human aBnion allografts (dHAM), and dehydrated human aBnion chorion tissue allografts (dHACM) poses advantages of pain relieving qualities, antibacterial and non-immunogenic properties, and reduction in inflammation and scar development in treatment of diabetic foot ulcers (DFU) and venous leg ulcers (VLU).
Rising preference for biosynthetic skin substitutes: Biosynthetic skin substitutes are engineered substitutes created from both biologic and synthetic materials that can closely mimic natural skin. Bioengineered Skin grafts offer improved compatibility with the human body as compared to fully synthetic skin grafts. This rising demand is driven by the ability of biosynthetic skin to integrate well with the native tissues and induce natural healing processes. They allow for regeneration of functional skin tissue and hence improve the clinical outcomes for patients who require treatment for burns and other skin wounds. For instance, as per Fact sheet of year 2020 published by American Burn Association, approximately 450,000 burns requiring medical attention occur each year in theU.S. Biosynthetic skin grafts can potentially help in the treatment of such patients and improve survival and recovery rates.
Growing focus on sustainability: The trend towards sustainability is also impacting the bioengineered artificial skin market, with increasing demand for eco-friendly and sustainable products. This trend is expected to drive the development of bioengineered skin substitutes made from sustainable and biodegradable materials. The increasing focus on sustainability and environment protection has pushed research and development (R&D) in bioengineered artificial skin. With increasing awareness about minimizing medical waste, researchers are exploring ways to develop bioengineered skin that is biodegradable and causes less environmental impact. Some of the leading companies in this sector are investing in producing artificial skin from biological materials like collagen and fibrin that can degrade naturally inside the human body once the healing process is complete. This allows avoiding disposal of synthetic skin patches in landfills or incineration after usage, making the treatment more eco-friendly. For instance, in 2020, according to clinical data published by Intercytex, U.K based regenerative medicine company in 2020, the bioengineered skin substitute of the company, dermaPure, gets incorporated into the patients' own regenerated skin within 4-6 weeks in 90% of acute wound cases, making the treatment fully biodegradable. Such shifts towards bioabsorbable substitutes demonstrate how sustainability concerns are reshaping innovation in this sector to develop greener medical alternatives.